Copyright
©The Author(s) 2021.
World J Orthop. Jun 18, 2021; 12(6): 395-402
Published online Jun 18, 2021. doi: 10.5312/wjo.v12.i6.395
Published online Jun 18, 2021. doi: 10.5312/wjo.v12.i6.395
Table 3 Results of multivariate regression analysis to evaluate the relative risk of complications in patients with idiopathic inflammatory myopathies compared with controls following total hip arthroplasty
Complication | OR (95%CI) | P value | |
Acute kidney injury | 0.034 | 1.035 (0.817-1.311) | 0.778 |
Cardiac arrest | 0.315 | 1.370 (0.712-2.636) | 0.346 |
Deep vein thrombosis | 0.423 | 1.526 (0.524-4.443) | 0.438 |
Nerve injury | -0.966 | 0.381 (0.039-3.687) | 0.405 |
Pneumonia1 | 0.376 | 1.456 (1.170-1.812) | 0.001 |
Pulmonary embolism1 | 0.378 | 1.460 (1.026-2.077) | 0.035 |
Urinary tract infection | 0.123 | 1.131 (0.931-1.374) | 0.215 |
Wound disruption | -0.249 | 0.780 (0.485-1.253) | 0.304 |
Hematoma1 | -0.542 | 0.582 (0.406-0.833) | 0.003 |
Transfusion | 0.060 | 1.062 (0.861-1.310) | 0.573 |
Capsulitis | 0.355 | 1.426 (0.952-2.137) | 0.085 |
Infection | -0.342 | 0.71 (0.442-1.139) | 0.156 |
- Citation: Rosas S, Schallmo M, Gowd AK, Akelman MR, Luo TD, Emory CL, Plate JF. Dermatomyositis and polymyositis in total hip arthroplasty. World J Orthop 2021; 12(6): 395-402
- URL: https://www.wjgnet.com/2218-5836/full/v12/i6/395.htm
- DOI: https://dx.doi.org/10.5312/wjo.v12.i6.395